跳到正文
原文
Medical Xpress·· 2026-10-08精选AI 评分68

研究显示近三分之一使用特定激素避孕药的育龄癫痫患者与酶诱导型抗癫痫药处方重叠

Common epilepsy medication and birth control combinations may reduce contraceptive effectiveness

AI 导读

一项基于美国 Medicaid 理赔数据的观察性研究显示,在 110,976 名服用抗癫痫药的育龄期癫痫患者中,近五分之一在 2018 至 2021 年间使用过可能受酶诱导型抗癫痫药影响的激素避孕药,其中近三分之一出现至少一次 14 天及以上的两类处方重叠。

推荐理由

基于美国 Medicaid 理赔数据,量化酶诱导型抗癫痫药与激素避孕药处方重叠的规模与时长,为用药咨询提供依据。

正文
contraceptives
Credit: Pixabay/CC0 Public Domain

Nearly one-third of people with epilepsy who were prescribed certain hormonal contraceptives also received antiseizure medications that may make those contraceptives less effective, according to a University of Pittsburgh–led study published in Neurology.

Some epilepsy medications may harm a developing fetus, so the findings point to a need for greater awareness of interactions between enzyme-inducing antiseizure medications and some hormonal contraceptives. These medications can accelerate the breakdown of contraceptive hormones in the body, potentially reducing protection against an unplanned pregnancy.

The researchers emphasize the importance of informed counseling and shared decision-making so that people with epilepsy can choose medication and contraceptive options that reflect their health needs and preferences.

"Pregnancy planning is especially important for people with epilepsy, but patients may not realize that some antiseizure medications can interact with some forms of hormonal contraception," said senior author Page B. Pennell, M.D., chair of the Department of Neurology at Pitt's School of Medicine.

"This study highlights an opportunity for neurologists, reproductive health clinicians, pharmacists and patients to have more coordinated conversations about medications, contraception and reproductive goals."

Using U.S. Medicaid claims data, the researchers identified 110,976 people with epilepsy of childbearing potential who were receiving antiseizure medications. Nearly 1 in 5 had received a hormonal contraceptive that could be affected by enzyme-inducing antiseizure medications between 2018 and 2021. The contraceptive methods included combined and progestin-only pills, contraceptive patches, vaginal rings and subdermal implants.

Among those individuals, nearly one-third experienced at least one period of 14 days or longer when prescriptions for a susceptible contraceptive and an enzyme-inducing antiseizure medication overlapped. Among people with an overlap, the median duration was 218 days, or just over seven months.

"These were not simply brief or isolated prescription overlaps," said corresponding author Laura Kirkpatrick, M.D., M.S., assistant professor of pediatrics and neurology at the University of Pittsburgh School of Medicine.

"For many people, the overlap continued for months. Clinicians should routinely consider potential drug interactions and make sure patients understand their options, including contraceptive methods that are not affected by enzyme-inducing antiseizure medications."

Certain groups were more likely to experience potentially reduced contraceptive effectiveness. People with intellectual disability had more than twice the odds of experiencing an overlap compared with people without intellectual disability. Those with drug-resistant epilepsy and those age 35 or older also had higher odds of overlap and longer periods of concurrent prescriptions.

Effective contraception can be particularly important for people with epilepsy because pregnancy can bring additional health considerations. Uncontrolled seizures and some antiseizure medications have been associated with risks to a developing fetus. An unplanned pregnancy may provide less opportunity to adjust medications to ones that are proven to be safe for both the mother and developing child.

The researchers noted that not all contraceptive methods are affected by these interactions. Intrauterine devices, including hormonal and copper devices, are not affected by enzyme-inducing antiseizure medications and may be discussed as an option when consistent with a patient's preferences. Co-use of an interacting medication combination may also be appropriate in some circumstances when a patient understands the potential risks and benefits.

Future research will examine pregnancy rates among people who received overlapping prescriptions and explore why these medication combinations are prescribed. The authors also call for research into interventions such as electronic health record alerts, pharmacist review and patient- and clinician-facing education to improve awareness and support shared decision-making.

Publication details

Contraceptive and Enzyme-Inducing Antiseizure Medication Co-Prescription Among U.S. Medicaid Beneficiaries with Epilepsy, Neurology (2026). DOI: 10.1212/WNL.0000000000218679

Journal information: Neurology

Key medical concepts

Epilepsy

Who's behind this story?

Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Alexander Pol

Alexander Pol

PhD nano-engineering from Delft University. Published researcher and journal reviewer. Brings scientific insight to content standards. Full profile →

Citation: Common epilepsy medication and birth control combinations may reduce contraceptive effectiveness (2026, October 7) retrieved 7 October 2026 from https://medicalxpress.com/news/2026-10-common-epilepsy-medication-birth-combinations.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com